Navigation Links
Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
Date:1/16/2012

MINNEAPOLIS, Jan. 16, 2012 /PRNewswire/ -- Zyga Technology, Inc. announced today that Jim Bullock has been named as the new President and CEO of the company.  Before joining Zyga Technology, Jim was President and CEO of Atritech, Inc. which was recently sold to Boston Scientific.  Prior to Atritech, Jim was President and CEO of Endocardial Solutions, Inc., which was acquired by St. Jude Medical. 

(Logo: http://photos.prnewswire.com/prnh/20110118/CG30384LOGO)

"I am extremely excited about the opportunities here at Zyga.  In today's environment, success is determined by products that are clinically validated to address the unmet needs of clinicians, and we are committed to meeting that challenge. We are excited about the traction we are gaining in the market with the SImmetry™ Sacroiliac Joint Fusion System, and the early clinical study results from the GLYDER™ Facet Resurfacing System. " said Jim Bullock

According to Dave Stassen, Chairman of the Board of Zyga Technology, Inc., and managing director of Split Rock Partners, "We are very pleased that Jim has joined the team at Zyga.  Jim has a phenomenal track record of creating value for start-up companies in the medical device industry.  Jim has been involved in medical devices throughout his career and brings a great deal of energy, commercialization success and strategic experience to Zyga."

Sacroiliac joint dysfunction and facetogenic pain have been shown to be the source of pain for up to 20% & 30% of patients suffering from low back pain respectively. Patients who suffer from these conditions typically receive therapeutic injections which temporarily address the problem but require long-term repeat treatments.  Traditional, open surgery has been performed to address these conditions but is limited in practice due to its complexity, high complication rate and generally poor outcomes.

About Zyga Technology, Inc.

Based in Minneapolis, MN, Zyga Technology, Inc. was founded to develop and market innovative, minimally invasive surgical solutions to treat conditions of the spine.  Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry.


'/>"/>
SOURCE Zyga Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
2. eResearchTechnology, Inc. to Present at the Thomas Weisel Healthcare Conference on September 4th, 2008
3. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
4. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
5. eResearchTechnology, Inc. to Announce 2008 Third Quarter Results on October 30, 2008
6. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
7. eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008
8. ERT (eResearchTechnology, Inc.) and Integrium, LLC Form Alliance to Deliver Integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring Services
9. Multisol France on Track to Sell 250 Tons of International Fuel Technology, Inc. Fuel Additive Formulations
10. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
11. Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):